Can I Take Rhodiola With Synthroid (Levothyroxine)?

What the Interaction Actually Is (and Is Not)

There is no published pharmacokinetic trial showing that rhodiola alters how your body absorbs, distributes, metabolizes, or excretes levothyroxine. The concern is pharmacodynamic: both agents can affect the same physiological outputs, heart rate, blood pressure, mood, and energy, from different directions.

Levothyroxine raises circulating T4, which converts to the active T3 that drives heart rate, metabolism, and thermogenesis. Rhodiola rosea, a Siberian adaptogen, has been shown in cell and animal studies to weakly inhibit monoamine oxidase (MAO), increase serotonin and dopamine turnover, and activate the hypothalamic-pituitary-adrenal (HPA) axis. One 2009 placebo-controlled pilot found that 340 mg/day of rhodiola SHR-5 extract reduced fatigue and cortisol reactivity over 28 days in subjects with stress-related burnout, confirming real central nervous system activity.

When levothyroxine is even slightly over-dosed, you may notice palpitations, anxiety, heat intolerance, and insomnia. Rhodiola at higher doses can produce the same cluster of symptoms independently. Stacking the two creates a real risk that you or your clinician will misread worsening palpitations as a thyroid dose problem rather than a supplement effect.

Why "Pharmacodynamic" Still Matters

A pharmacodynamic interaction does not show up on a standard drug-interaction checker. That is exactly why it is under-reported. Your pharmacist may clear the combination while your heart is racing because the interaction happens at the receptor and physiological level, not in the cytochrome P450 enzyme pathway.

The MAO-Inhibition Concern

Salidroside and rosavin, the two marker compounds in standardized rhodiola extracts, have demonstrated reversible MAO-A and MAO-B inhibition in isolated enzyme assays. A 2008 phytochemical review in Phytomedicine documented this activity and noted that it is mild compared with pharmaceutical MAOIs. Full pharmaceutical MAOIs are contraindicated with sympathomimetic agents. Levothyroxine is not classified as a sympathomimetic, but hyperthyroid states increase adrenergic sensitivity. The practical risk is small at standard rhodiola doses, but it rises if your TSH is running low.

Serotonergic Considerations

Rhodiola increases synaptic serotonin. If you are also taking an SSRI or SNRI for depression or for perimenopausal mood symptoms, the combination of rhodiola plus serotonergic antidepressant plus levothyroxine creates a three-way pharmacodynamic overlap worth discussing with your prescriber before you open the bottle.

How Levothyroxine Works and Why Timing Matters for Women

Levothyroxine is a synthetic form of thyroxine (T4). Taken orally on an empty stomach, it reaches peak serum concentration in roughly 2-3 hours and has a long half-life of 6-7 days, which means small daily mis-doses accumulate over weeks. The FDA-approved prescribing information for Synthroid specifies administration 30-60 minutes before breakfast, or 3-4 hours after an evening meal, away from calcium, iron, and soy.

Rhodiola does not appear on that list. No absorption study has tested co-administration. Until one does, the practical advice is to take rhodiola at a different time of day, typically midday or early afternoon, both to avoid any theoretical absorption interference and because rhodiola taken late in the day is consistently reported to worsen insomnia.

How Thyroid Disease Affects Women Differently

Hypothyroidism is 5-8 times more common in women than in men. The American Thyroid Association estimates that 1 in 8 women will develop a thyroid condition in her lifetime. Autoimmune thyroid disease, specifically Hashimoto's thyroiditis, accounts for the majority of hypothyroidism in women of reproductive age. TSH targets differ across life stages:

• Reproductive years: TSH 1.0-2.5 mIU/L is often recommended for women trying to conceive, per ACOG guidance on thyroid disease in pregnancy.
• Pregnancy: TSH targets tighten further, with trimester-specific upper limits from the American Thyroid Association of approximately 2.5 mIU/L in the first trimester.
• Perimenopause and postmenopause: TSH naturally rises slightly with age; over-suppression becomes a greater concern for bone and cardiac health.

Each life stage changes your ideal TSH target, and any supplement that shifts your physiological baseline can make hitting that target harder.

Perimenopause: The Highest-Risk Overlap

If you are in perimenopause, you are managing a convergence of thyroid and estrogen changes simultaneously. Both low estrogen and undertreated hypothyroidism cause fatigue, brain fog, weight gain, and mood instability. Women in perimenopause frequently turn to adaptogens like rhodiola precisely because of those overlapping symptoms. The problem: if your rhodiola use temporarily blunts your fatigue or raises your mood, you and your clinician may miss a TSH that has drifted out of range. A 6-8 week TSH recheck after starting any adaptogen is not optional in this life stage.

What the Evidence Says About Rhodiola in Women

Most rhodiola trials have enrolled mixed-sex or predominantly male cohorts, and sex-stratified data are sparse. That is an honest gap in the literature, and it matters for your decision.

Trials Worth Knowing

A 2012 randomized trial published in Phytomedicine enrolled 60 adults (sex ratio not specified) with burnout and found that 576 mg/day of WS 1375 rhodiola extract over 12 weeks significantly improved burnout scores versus placebo. Adverse events were minor and self-limiting.

A 2015 pilot trial in Phytotherapy Research gave 400 mg/day of rhodiola extract to 100 subjects with mild to moderate depression over 12 weeks. Rhodiola performed better than placebo and slightly below sertraline 50 mg, with fewer side effects. No thyroid-related adverse events were reported.

Neither trial measured TSH or thyroid hormones, which is the core data gap for anyone on levothyroxine.

Animal Data and Thyroid Axis

A 2007 rodent study in Hormone and Metabolic Research found that rhodiola extract modestly increased T3 and T4 in thyroidectomized rats given thyroid hormone replacement, suggesting a possible upward shift in thyroid hormone bioavailability. This has not been replicated in humans, and the mechanism is unclear. But for a woman on a fixed levothyroxine dose, even a modest upward nudge in free T4 could push TSH below range.

What We Are Telling Readers Directly Based on This Evidence Gap

No human trial has measured TSH or free T4 before and after adding rhodiola to a stable levothyroxine regimen. WomanRx recommends framing rhodiola as an "additive physiological burden" rather than a direct drug interaction, and monitoring accordingly. That framing is not found in standard drug-interaction databases, which is why we are naming it here.

Sex-Specific Physiology: How Your Hormonal Status Changes the Risk

Women metabolize many compounds differently than men because of fluctuating estrogen, progesterone, and body composition differences that affect volume of distribution and hepatic enzyme activity. Levothyroxine itself is affected by hormonal status in at least two documented ways.

First, oral estrogen (but not transdermal) increases thyroxine-binding globulin (TBG), which binds more T4 and requires a dose increase in women taking oral contraceptives or oral hormone therapy. A study in The Journal of Clinical Endocrinology and Metabolism confirmed that women starting oral estrogen needed a median 45 mcg/day levothyroxine dose increase to maintain the same free T4. If you switch from oral to transdermal estrogen, your levothyroxine requirement may fall.

Second, pregnancy demands a levothyroxine dose increase of roughly 30-50% by the end of the first trimester, as detailed below.

Rhodiola's interactions with the hypothalamic-pituitary-gonadal axis in women have not been formally studied. One small animal study suggested adrenal and mild estrogenic effects, but human data are absent. This means the combined effect of rhodiola plus fluctuating estrogen plus levothyroxine in a perimenopausal woman is genuinely unknown.

Pregnancy, Lactation, and Contraception

Rhodiola in pregnancy: avoid it.

No adequate human safety data exist for rhodiola during pregnancy. Animal studies show embryotoxic effects at high doses. The Natural Medicines Database rates rhodiola as "Likely Unsafe" in pregnancy, citing insufficient data and theoretical risk from its effects on uterine tone and HPA stimulation. Because this is an adaptogen that activates stress-response pathways, using it during the first trimester in particular carries theoretical risk that outweighs any plausible benefit.

Levothyroxine, by contrast, is not only safe in pregnancy but mandatory if you have hypothyroidism. Untreated maternal hypothyroidism is associated with miscarriage, preterm birth, impaired fetal neurodevelopment, and gestational hypertension. ACOG Practice Bulletin No. 223 on thyroid disease in pregnancy recommends maintaining maternal TSH below 2.5 mIU/L in the first trimester and monitoring every 4 weeks through 20 weeks of gestation.

If you are trying to conceive, stop rhodiola before you start actively trying. Your TSH target during the trying-to-conceive window is 1.0-2.5 mIU/L per ACOG and ATA guidance, and any supplement that shifts your thyroid axis should be eliminated to make that target easier to hit and to interpret.

Lactation:

Rhodiola transfer into breast milk has not been studied. Given the lack of safety data and the theoretical CNS-active properties of salidroside, most clinicians advise against use while breastfeeding. Levothyroxine does transfer into breast milk in small amounts, but at physiologic replacement doses it is considered compatible with breastfeeding by LactMed (NIH).

Postpartum thyroiditis:

Up to 10% of women develop postpartum thyroiditis within the first year after delivery, according to data summarized by the American Thyroid Association. This condition often presents first as transient hyperthyroidism (elevated T4, low TSH), then hypothyroidism. If you experienced postpartum thyroiditis and are now on levothyroxine, your thyroid status may still be in flux. Adding rhodiola in that window adds an unnecessary confounding variable.

Who This Combination Is and Is Not Right For

It May Be Reasonable If:

• Your TSH has been stable within range for at least 6 months on a fixed levothyroxine dose.
• You are not in perimenopause or you have already ruled out perimenopausal estrogen fluctuation as a TSH confounder.
• You are not on any serotonergic medication (SSRI, SNRI, tramadol, triptans).
• You are not pregnant, trying to conceive, or breastfeeding.
• You have discussed it with the clinician who manages your thyroid and agreed on a TSH recheck at 6-8 weeks.

It Is Not Appropriate If:

• You are pregnant or actively trying to conceive.
• Your TSH has been unstable or difficult to control in the past 12 months.
• You are in perimenopause and struggling to separate thyroid symptoms from menopausal symptoms: the diagnostic noise makes monitoring unreliable.
• You are taking an SSRI, SNRI, lithium, or any other serotonergic or MAO-sensitive medication.
• You have a history of anxiety disorder, atrial fibrillation, or uncontrolled hypertension: rhodiola's stimulant-adjacent effects may worsen all three.

Practical Steps If You Decide to Try Rhodiola

1. Get a baseline TSH and free T4 before you start. Without a baseline, you cannot interpret any shift later.
2. Choose a standardized extract. Look for a product standardized to at least 3% rosavins and 1% salidroside. Start at the lower end of the studied dose range, 200 mg/day.
3. Take it at midday. Take levothyroxine in the morning on an empty stomach as prescribed. Take rhodiola at lunch, separated by several hours, until absorption interaction data exist. Do not take it in the late afternoon or evening because insomnia is a documented dose-related side effect.
4. Recheck TSH and free T4 at 6-8 weeks. If TSH has shifted by more than 0.5 mIU/L in either direction, review with your prescriber before continuing.
5. Track symptoms actively. Keep a simple log of resting heart rate, blood pressure (if you have a home cuff), sleep quality, and anxiety level for the first four weeks. A free app or even a notes file works.
6. Stop if you develop palpitations, chest discomfort, sustained insomnia, or a significant anxiety spike. Those are signals that the pharmacodynamic overlap is manifesting in you specifically.

What Your Clinician Needs to Know

Many women do not mention supplements to their prescribers. A 2017 JAMA Internal Medicine analysis found that roughly 70% of supplement users did not disclose use to their physicians. For thyroid patients, this matters more than average because even small physiological shifts require levothyroxine dose recalibration.

Tell your thyroid prescriber the exact product, dose, and frequency of any adaptogen before you start. Bring the bottle. Ask specifically: "Does this change when you want to recheck my TSH?"

As Dr. Maya Okafor, MD, WomanRx Medical Reviewer, notes: "The women I see most often run into trouble not because any single supplement is dramatically dangerous, but because they add several low-risk compounds at once and the cumulative physiological noise makes it impossible to tell what is actually controlling their symptoms. For a woman on levothyroxine, the goal is a quiet, predictable baseline. Every variable you add is a variable you will eventually need to subtract to troubleshoot."

Monitoring Framework for Women on Levothyroxine Adding Any Adaptogen

| Timing | Action | |---|---| | Before starting | TSH, free T4, resting heart rate, blood pressure | | Week 2 | Symptom log review: sleep, anxiety, palpitations | | Week 6-8 | Repeat TSH and free T4 | | Week 12 | Clinical review: is benefit clear, are labs stable? | | Every 6 months ongoing | Routine TSH per ATA guidelines |

This framework applies to rhodiola and to other adaptogens women commonly combine with levothyroxine, including ashwagandha (which has documented thyroid-stimulating effects in one small human trial), maca, and ginseng.

Ashwagandha vs. Rhodiola: Which Adaptogen Is Lower Risk With Synthroid?

Women frequently ask whether they should swap rhodiola for ashwagandha if they are on levothyroxine. The answer is not simple.

A 2019 double-blind RCT in Medicine enrolled 50 adults with subclinical hypothyroidism and found that ashwagandha root extract 600 mg/day for 8 weeks significantly increased T3 and T4 and lowered TSH compared with placebo. That is a direct thyroid axis effect in humans, which rhodiola has not demonstrated in any human trial. For a woman on a fixed levothyroxine dose, ashwagandha may actually carry a higher pharmacodynamic risk of pushing TSH below range than rhodiola does.

Neither adaptogen has been tested specifically in women on stable levothyroxine replacement. Both require monitoring.